Viking Therapeutics, Inc. (VKTX)
36.75
-4.90
(-11.76%)
USD |
NASDAQ |
Sep 24, 16:00
37.51
+0.76
(+2.07%)
Pre-Market: 08:39
Viking Therapeutics Gross Profit (Annual) : -0.431M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.431M |
| December 31, 2024 | -0.346M |
| December 31, 2023 | -0.292M |
| December 31, 2022 | -0.291M |
| December 31, 2021 | -0.296M |
| December 31, 2020 | -0.277M |
| December 31, 2019 | -0.26M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Eli Lilly & Co. | 54.13B |
| Regeneron Pharmaceuticals, Inc. | 11.70B |
| Ironwood Pharmaceuticals, Inc. | 294.27M |
| Xencor, Inc. | 115.06M |